Beyond Bulls & Bears

Ozempic can’t help your overweight in big tech: Global ETF diversification ideas for 2024
ETFs

Ozempic can’t help your overweight in big tech: Global ETF diversification ideas for 2024

The start of a new year brings a chance for reflection and re-evaluation. For investors, a chance to rebalance. Franklin Templeton ETFs’ Dina Ting and Marcus Weyerer highlight the pitfalls of overweight exposure to mega tech stocks and where in the world to look for diversification in 2024.